We are live on ! Find out more
NYLIM

New York Life Investment Management Portfolio holdings

AUM $14.3B
1-Year Est. Return 34.42%
This Fund
S&P 500
This Quarter Est. Return
-12.74%
1 Year Est. Return
+34.42%
3 Year Est. Return
+100.17%
5 Year Est. Return
+116.66%
10 Year Est. Return
+182.12%
AUM
$8.62B
AUM Growth
+$6.73B
Cap. Flow
+$7.54B
Cap. Flow %
87.45%
Top 10 Hldgs %
25.4%
Holding
1,256
New
1,204
Increased
26
Reduced
16
Closed
6

Sector Composition

Rank Sector Weight
1 Technology 17.38%
2 Healthcare 9.71%
3 Financials 8.46%
4 Consumer Discretionary 6.79%
5 Industrials 6.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVTR icon
1101
Avantor
AVTR
$9.41B
$341K ﹤0.01%
+10,958
New +$342K
MCHB
1102
Mechanics Bancorp
MCHB
$3.82B
$341K ﹤0.01%
+9,843
New +$396K
MODV
1103
DELISTED
ModivCare
MODV
$341K ﹤0.01%
+4,041
New +$408K
AAN
1104
DELISTED
The Aaron's Company Inc
AAN
$338K ﹤0.01%
+23,224
New +$443K
ACGL icon
1105
Arch Capital
ACGL
$33.4B
$336K ﹤0.01%
+7,379
New +$342K
CNO icon
1106
CNO Financial Group
CNO
$5.08B
$336K ﹤0.01%
+18,587
New +$397K
MYGN icon
1107
Myriad Genetics
MYGN
$309M
$336K ﹤0.01%
+18,506
New +$384K
OFIX icon
1108
Orthofix Medical
OFIX
$427M
$336K ﹤0.01%
+14,261
New +$408K
KAMN
1109
DELISTED
Kaman Corp
KAMN
$335K ﹤0.01%
+10,725
New +$398K
AMCX icon
1110
AMC Global Media
AMCX
$490M
$334K ﹤0.01%
+11,478
New +$405K
DLX icon
1111
Deluxe
DLX
$1.11B
$334K ﹤0.01%
+15,421
New +$393K
ACH
1112
Accendra Health
ACH
$86.9M
$333K ﹤0.01%
+10,594
New +$384K
VECO icon
1113
Veeco
VECO
$3.28B
$333K ﹤0.01%
+17,151
New +$381K
AAWW
1114
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
$333K ﹤0.01%
+5,399
New +$369K
APG icon
1115
APi Group
APG
$18.7B
$332K ﹤0.01%
+33,263
New +$392K
VRTS icon
1116
Virtus Investment Partners
VRTS
$1.13B
$332K ﹤0.01%
+1,943
New +$367K
VXX icon
1117
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$142M
$332K ﹤0.01%
+900
New +$355K
WHD icon
1118
Cactus
WHD
$5.78B
$331K ﹤0.01%
+8,219
New +$413K
ENV
1119
DELISTED
ENVESTNET, INC.
ENV
$331K ﹤0.01%
+6,265
New +$428K
IMVT icon
1120
Immunovant
IMVT
$8.78B
$330K ﹤0.01%
+84,635
New +$366K
QAI icon
1121
NYLI Hedge Multi-Strategy Tracker ETF
QAI
$1.03B
$330K ﹤0.01%
+11,508
New +$341K
NKTR icon
1122
Nektar Therapeutics
NKTR
$2.57B
$329K ﹤0.01%
+5,768
New +$364K
CASH icon
1123
Pathward Financial
CASH
$1.8B
$328K ﹤0.01%
+8,491
New +$362K
CBRL icon
1124
Cracker Barrel
CBRL
$1.33B
$328K ﹤0.01%
+3,928
New +$408K
OSW icon
1125
OneSpaWorld
OSW
$2.7B
$328K ﹤0.01%
+45,720
New +$423K

Similar funds

New York Life Investment Management's Q2 2022 Portfolio in Review

As of Q2 2022, New York Life Investment Management held 1,256 positions worth $8.62B, up 355% from $1.89B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

New York Life Investment Management deployed $7.54B of net new capital in Q2 2022, opening 1,204 new positions and adding to 26 existing holdings. Its largest new stake was Apple: 2,435,584 shares worth $333M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, followed by Healthcare and Financials.

On the sell side, the largest reduction was IQ Candriam US Large Cap Equity ETF, an estimated $21.2M trimmed.

  • New York Life Investment Management's largest Q2 2022 buy was Apple: 2,435,584 shares worth $333M.
  • New York Life Investment Management added most to NYLI MacKay Core Plus Bond ETF in Q2 2022, an estimated $120M increase.
  • New York Life Investment Management's biggest Q2 2022 reduction was IQ Candriam US Large Cap Equity ETF, cutting an estimated $21.2M.
  • New York Life Investment Management fully exited iShares MSCI EAFE Small-Cap ETF in Q2 2022, selling an estimated $3.12M.
  • New York Life Investment Management's ten largest holdings make up 25% of its $8.62B portfolio in Q2 2022.
  • New York Life Investment Management opened 1,204 new positions and closed 6 in Q2 2022.
  • New York Life Investment Management's portfolio value rose 355% quarter-over-quarter to $8.62B.

Based on New York Life Investment Management's 13F filing for Q2 2022, filed 12 Aug 2022.